Levels of placenta growth factor in gestational trophoblastic diseases

American Journal of Obstetrics and Gynecology

Volumn 188, Issue 1, 2003, Pages 135-140

  Okamoto, Tomomitsu ^a   Niu, Rong ^b   Mizutani, Shigehiko ^b   Yamada, Satoru ^b  

^a CHUKYO HOSPITAL   (Japan)

^b NONE

Author keywords

Gestational trophoblastic disease; Placenta growth factor; Serum; Tissue

Indexed keywords

CHORIONIC GONADOTROPIN; GROWTH FACTOR; PLACENTAL GROWTH FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CHORIOCARCINOMA; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; HYDATIDIFORM MOLE; PLACENTA; PREGNANCY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TISSUE HOMOGENATE; TROPHOBLASTIC DISEASE;

EID: 0037252531     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2003.71     Document Type: Article

References (20)

1. Kohorn EI. Hydatidiform mole and gestational trophoblastic disease in southern Connecticut. Obstet Gynecol 1982;59:78-84.
2. Lurain JR, Brewer JI, Torok EE, Halpern B. Natural history of hydatidiform mole after primary evacuation. Am J Obstet Gynecol 1983;145:591-5.
3. Park JE, Chen HH, Winer J, Houck KA, Ferrara N. Placenta growth factor: potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. J Biol Chem 1994;269:25646-54.
4. Maglione D, Guerriero V, Viglietto G, Delli-Bovi P, Persico MR. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci U S A 1991;88:9267-71.
5. Shore VH, Wang TH, Wang CL, Torry RJ, Caudle MR, Torry DS. Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast. Placenta 1997; 18:657-65.
6. Clark DE, Smith SK, Licence D, Evans AI, Charnock-Jones DS. Comparison of expression patterns for placenta growth factor, vascular endothelial growth factor (VEGF), VEGF-B and VEGF-C in the human placenta throughout gestation. J Endocrinol 1998;159:459-67.
7. Torry DS, Wang H-S, Wang T-H, Caudle MR, Torry RJ. Preeclampsia is associated with reduced serum levels of placenta growth factor. Am J Obstet Gynecol 1998;179:1539-44.
8. Reuvekamp A, Velsing-Aarts FV, Poulina IEJ, Capello JJ, Duits AJ. Selective deficit of angiogenic growth factors characterises pregnancies complicated by pre-eclampsia. Br J Obstet Gynaecol 1999;106:1019-22.
9. Livingston JC, Chin R, Haddad B, McKinney ET, Ahokas RA, Ramsey R, et al. Reduction of vascular endothelial growth factor and placental growth factor concentrations in severe preeclampsia. Am J Obstet Gynecol 2000;183:1554-7.
10. Livingston JC, Haddad B, Gorski LA, Neblett P, Ahokas RA, Ramsey R, et al. Placenta growth factor is not an early marker for the development of severe preeclampsia. Am J Obstet Gynecol 2001;184:1218-20.
11. Tidwell SC, Ho H-N, Chiu W-H, Torry RJ, Torry DS. Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia. Am J Obstet Gynecol 2001;184:1267-72.
12. Su YN, Lee CN, Cheng WF, Shau WY, Chow SN, Hsieh FJ. Decreased maternal serum placenta growth factor in early second trimester and preeclampsia. Obstet Gynecol 2001;97:898-904.
13. Tjoa ML, van Vugt JMG, Mulders MAM, Schutgens RBH, Oudejans CBM, van Wijk IJ. Plasma placenta growth factor levels in midtrimester pregnancies. Obstet Gynecol 2001;98:600-7.
14. Ong CYT, Liao AW, Cacho AM, Spencer K, Nicolaides KH. First-trimester maternal serum levels of placenta growth factor as predictor of preeclampsia and fetal growth restriction. Obstet Gynecol 2001;98:608-11.
15. Okamoto T, Nomura S, Nakanishi T, Goto S, Tomoda Y, Mizutani M. Choriocarcinoma diagnostic score: a scoring system to differentiate choriocarcinoma from invasive mole. Int J Gynecol Cancer 1998;8:128-32.
16. Fox H. Trophoblastic disease. Int J Clin Oncol 2000;5:71-8.
17. Bae SN, Kim SJ. Telomerase activity in complete hydatidiform mole. Am J Obstet Gynecol 1999;180:328-33.
18. Cheung ANY, Zhang DK, Liu Y, Ngan HYS, Shen DH, Tsao SW. Telomerase activity in gestational trophoblastic disease. J Clin Pathol 1999;52:588-92.
19. Tuncer ZS, Vegh GL, Fulop V, Genest DR, Mok SC, Berkowitz RS. Expression of epidermal growth factor receptor-related family products in gestational trophoblastic diseases and normal placenta and its relationship with development of postmolar tumor. Gynecol Oncol 1999;77:389-93.
20. Iwase K, Okamoto T, Nui R, Mizutani S. Expression of nm23-H1 in hydatidiform mole and its relationship with the development of postmolar disease. Gynecol Obstet Invest 2001;51:228-32.